Contact Us
Please Contact Us

toll free: 1800 3070 6727    Email:

Celsee CTC is a USA-FDA approved test for cancer monitoring. This test is for breast, colorectal or prostate cancer patients. It is done at repeated intervals to see how treatment is progressing. It is a must for patients who want to keep exact track of their cancer’s progress.


Reports provides information that allows physicians to:

  • Better understand a patients’ risk for specific health conditions

  • Prescribe more suitable medications at optimal dosages for patients, as needed.

  • Suggest early lifestyle and diet interventions to help control or prevent certain health conditions.

Related Tests

  • PositiveSelect Match

    31% more accurate in identifying cancer driver mutations

    Better treatment recommendation

    Complementary consultation with your doctor

    INR 93925
    INR 110500

  • images/PBSelectLite

    Test all NCCN recommended genes of patients tumor type

    Test for 100 genes including EGFR, KRAS, PIK3CA, HER2, BRAF in affordable price

    Replaces most routine diagnostic tests in Lung, Ovarian, Kidney, Pancreatic, Colorectal Cancer with superior accuracy

    INR 27625
    INR 32500

  • egfr

    US FDA approved

    Detects resistance mutation T790M in EGFR positive patients

    A substitute for second biopsy

    INR 27625
    INR 32500

Copyright ©2017 Positive Bioscience, Inc. All Rights Reserved